Related Experiment Video
Updated: Aug 8, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
Published on: May 10, 2016
Food and Drug Administration risk assessment--process and toxicologic pathology
1Pathology Branch, U.S. Food and Drug Administration, Washington, D.C. 20204, USA.
Abstract:
A general outline of the risk assessment process at the Center for Food Safety and Applied Nutrition (CFSAN) of the Food and Drug Administration based on the toxicologic evaluation of data is described. Examples of recent pathology evaluations are presented to illustrate primarily the pathology review process at the CFSAN. These examples include the review of data from rodent studies from proposed indirect food additives and data from dog studies submitted in support of an investigational new drug, a short-acting opioid, proposed as an anesthetic in humans.
Related Concept Videos
Drug Regulation
Preclinical Development: Overview
Drug Toxicity: Overview
Drug Toxicity: Dose-Dependent Reactions
Toxicokinetics: Overview
Toxicity Testing in Animals

